• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 COVID-19 中调节性 T 细胞的研究:系统综述。

Toward an understanding of regulatory T cells in COVID-19: A systematic review.

机构信息

Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

出版信息

J Med Virol. 2021 Jul;93(7):4167-4181. doi: 10.1002/jmv.26891. Epub 2021 Apr 1.

DOI:10.1002/jmv.26891
PMID:33605463
Abstract

A more detailed understanding of Treg cells in COVID-19 infection will broaden our knowledge of the COVID-19 immunopathology and give us more insight into the curative immune-based strategies. We systematically searched electronic databases (PubMed, Google Scholar, EMBASE) and identified 18 eligible studies. Despite the inconsistencies between the results, we observed a trend toward decreasing Treg levels in severe COVID-19 patients. This finding underlines the hypothesis that Tregs play a role in the pathogenesis of COVID-19. Further studies on Tregs' functional aspects are necessary to illustrate Tregs' potential role in COVID-19 disease.

摘要

更详细地了解 COVID-19 感染中的 Treg 细胞将拓宽我们对 COVID-19 免疫病理学的认识,并使我们更深入地了解基于免疫的治疗策略。我们系统地检索了电子数据库(PubMed、Google Scholar、EMBASE),并确定了 18 项符合条件的研究。尽管结果存在差异,但我们观察到严重 COVID-19 患者的 Treg 水平呈下降趋势。这一发现支持了 Tregs 在 COVID-19 发病机制中起作用的假说。进一步研究 Tregs 的功能方面对于阐明 Tregs 在 COVID-19 疾病中的潜在作用是必要的。

相似文献

1
Toward an understanding of regulatory T cells in COVID-19: A systematic review.针对 COVID-19 中调节性 T 细胞的研究:系统综述。
J Med Virol. 2021 Jul;93(7):4167-4181. doi: 10.1002/jmv.26891. Epub 2021 Apr 1.
2
Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.轻度 COVID-19 患者血液中单核细胞来源的髓样抑制细胞增加,但调节性 T 淋巴细胞减少。
Viral Immunol. 2021 Nov;34(9):639-645. doi: 10.1089/vim.2021.0044. Epub 2021 Sep 16.
3
The role of CD4FoxP3 regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.CD4FoxP3调节性T细胞在新型冠状病毒肺炎免疫发病机制中的作用:对治疗的启示
Int J Biol Sci. 2021 Apr 10;17(6):1507-1520. doi: 10.7150/ijbs.59534. eCollection 2021.
4
Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients.调节性 T 细胞可预测住院 COVID-19 患者的临床病程。
Front Immunol. 2021 Dec 2;12:789735. doi: 10.3389/fimmu.2021.789735. eCollection 2021.
5
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.单细胞分析揭示严重 COVID-19 感染中的 T 细胞过度激活和瘫痪。
Front Immunol. 2020 Oct 8;11:589380. doi: 10.3389/fimmu.2020.589380. eCollection 2020.
6
Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review.调节性 T 细胞在 COVID-19 发病机制和严重程度中的作用:一项系统评价。
Arch Iran Med. 2022 Feb 1;25(2):127-132. doi: 10.34172/aim.2022.22.
7
Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.根据CT评分严重程度分析新型冠状病毒肺炎患者的细胞因子和白细胞亚群概况
Viruses. 2021 May 11;13(5):880. doi: 10.3390/v13050880.
8
COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.COVID-19 免疫病理学,重点关注 Th17 反应和基于细胞的免疫调节治疗:潜在靶点和挑战。
Scand J Immunol. 2022 Feb;95(2):e13131. doi: 10.1111/sji.13131. Epub 2022 Jan 3.
9
The Dynamic Role of FOXP3 Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection.FOXP3+Tregs 的动态作用及其在 SARS-CoV-2 感染期间的潜在治疗应用。
Front Immunol. 2022 Jul 8;13:916411. doi: 10.3389/fimmu.2022.916411. eCollection 2022.
10
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults.无症状和轻度 SARS-CoV-2 感染在儿童中引起的免疫激活低于成人,特异性中和抗体水平高于成人。
Front Immunol. 2021 Sep 30;12:741796. doi: 10.3389/fimmu.2021.741796. eCollection 2021.

引用本文的文献

1
Regulatory T cells: Supporting lung homeostasis and promoting resolution and repair after lung injury.调节性 T 细胞:支持肺稳态,并在肺损伤后促进其解决和修复。
Int J Biochem Cell Biol. 2024 May;170:106568. doi: 10.1016/j.biocel.2024.106568. Epub 2024 Mar 20.
2
Accelarated immune ageing is associated with COVID-19 disease severity.加速的免疫衰老与新冠病毒疾病的严重程度相关。
Immun Ageing. 2024 Jan 11;21(1):6. doi: 10.1186/s12979-023-00406-z.
3
COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity.
COVID-19 患者的淋巴细胞亚群发生变化,功能失调的 CD8lo T 细胞频率更高,与疾病严重程度相关。
Front Immunol. 2023 Sep 21;14:1223730. doi: 10.3389/fimmu.2023.1223730. eCollection 2023.
4
The TIGIT T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation.TIGIT+T 调节细胞亚群与机械通气的 COVID-19 患者院内感染和死亡结局相关。
Sci Rep. 2023 Aug 21;13(1):13599. doi: 10.1038/s41598-023-39924-7.
5
Differential regulatory T cell signature after recovery from mild COVID-19.轻症 COVID-19 康复后差异化调节性 T 细胞特征。
Front Immunol. 2023 Mar 8;14:1078922. doi: 10.3389/fimmu.2023.1078922. eCollection 2023.
6
CD4+ T Cell Regulatory Network Underlies the Decrease in Th1 and the Increase in Anergic and Th17 Subsets in Severe COVID-19.CD4+ T细胞调节网络是重症COVID-19中Th1细胞减少以及无反应性和Th17亚群增加的基础。
Pathogens. 2022 Dec 22;12(1):18. doi: 10.3390/pathogens12010018.
7
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients.Tfr、Tph 和非典型 B 细胞之间存在性别偏向性失衡,决定了 COVID-19 患者的抗体反应。
Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2217902120. doi: 10.1073/pnas.2217902120. Epub 2023 Jan 20.
8
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?恢复期 COVID-19 患者调节性 T 细胞动态的范围综述——提示其可能参与长新冠的发生?
Front Immunol. 2022 Dec 13;13:1070994. doi: 10.3389/fimmu.2022.1070994. eCollection 2022.
9
Cellular immune states in SARS-CoV-2-induced disease.SARS-CoV-2 诱导疾病中的细胞免疫状态。
Front Immunol. 2022 Nov 23;13:1016304. doi: 10.3389/fimmu.2022.1016304. eCollection 2022.
10
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.抗原特异性 T 细胞与 SARS-CoV-2 感染:当前方法与未来可能。
Int J Mol Sci. 2022 Dec 1;23(23):15122. doi: 10.3390/ijms232315122.